Cargando…
Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study
BACKGROUND: Many hospitals postponed elective surgical care during the first wave of the coronavirus disease 2019 (COVID-19) pandemic. Some centers continued elective surgery, including esophageal cancer surgery, with the use of preoperative screening methods; however, there is no evidence supportin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028574/ https://www.ncbi.nlm.nih.gov/pubmed/33830357 http://dx.doi.org/10.1245/s10434-021-09886-z |
_version_ | 1783675978673815552 |
---|---|
author | Borgstein, Alexander B. J. Brunner, Stefanie Hayami, Masaru Moons, Johnny Fuchs, Hans Eshuis, Wietse J. Gisbertz, Suzanne S. Bruns, Christiane J. Nafteux, Philippe Nilsson, Magnus Schröder, Wolfgang van Berge Henegouwen, Mark I. |
author_facet | Borgstein, Alexander B. J. Brunner, Stefanie Hayami, Masaru Moons, Johnny Fuchs, Hans Eshuis, Wietse J. Gisbertz, Suzanne S. Bruns, Christiane J. Nafteux, Philippe Nilsson, Magnus Schröder, Wolfgang van Berge Henegouwen, Mark I. |
author_sort | Borgstein, Alexander B. J. |
collection | PubMed |
description | BACKGROUND: Many hospitals postponed elective surgical care during the first wave of the coronavirus disease 2019 (COVID-19) pandemic. Some centers continued elective surgery, including esophageal cancer surgery, with the use of preoperative screening methods; however, there is no evidence supporting the safety of this strategy as postoperative outcomes after esophageal cancer surgery during the COVID-19 pandemic have not yet been investigated. METHODS: This multicenter study in four European tertiary esophageal cancer referral centers included consecutive adult patients undergoing elective esophageal cancer surgery from a prospectively maintained database in a COVID-19 pandemic cohort (1 March 2020–31 May 2020) and a control cohort (1 October 2019–29 February 2020). The primary outcome was the rate of respiratory failure requiring mechanical ventilation. RESULTS: The COVID-19 cohort consisted of 139 patients, versus 168 patients in the control cohort. There was no difference in the rate of respiratory failure requiring mechanical ventilation (13.7% vs. 8.3%, p = 0.127) and number of pulmonary complications (32.4% vs. 29.9%, p = 0.646) between the COVID-19 cohort and the control cohort. Overall, postoperative morbidity and mortality rates were comparable between both cohorts. History taking and reverse transcription polymerase chain reaction (RT-PCR) were used as preoperative screening methods to detect a possible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in all centers. No patients were diagnosed with COVID-19 pre- or postoperatively. CONCLUSION: Esophageal cancer surgery during the first wave of the COVID-19 pandemic was not associated with an increase in pulmonary complications as no patients were diagnosed with COVID-19. Esophageal cancer surgery can be performed safely with the use of adequate preoperative SARS-CoV-2 screening methods. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-09886-z. |
format | Online Article Text |
id | pubmed-8028574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80285742021-04-08 Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study Borgstein, Alexander B. J. Brunner, Stefanie Hayami, Masaru Moons, Johnny Fuchs, Hans Eshuis, Wietse J. Gisbertz, Suzanne S. Bruns, Christiane J. Nafteux, Philippe Nilsson, Magnus Schröder, Wolfgang van Berge Henegouwen, Mark I. Ann Surg Oncol Gastrointestinal Oncology BACKGROUND: Many hospitals postponed elective surgical care during the first wave of the coronavirus disease 2019 (COVID-19) pandemic. Some centers continued elective surgery, including esophageal cancer surgery, with the use of preoperative screening methods; however, there is no evidence supporting the safety of this strategy as postoperative outcomes after esophageal cancer surgery during the COVID-19 pandemic have not yet been investigated. METHODS: This multicenter study in four European tertiary esophageal cancer referral centers included consecutive adult patients undergoing elective esophageal cancer surgery from a prospectively maintained database in a COVID-19 pandemic cohort (1 March 2020–31 May 2020) and a control cohort (1 October 2019–29 February 2020). The primary outcome was the rate of respiratory failure requiring mechanical ventilation. RESULTS: The COVID-19 cohort consisted of 139 patients, versus 168 patients in the control cohort. There was no difference in the rate of respiratory failure requiring mechanical ventilation (13.7% vs. 8.3%, p = 0.127) and number of pulmonary complications (32.4% vs. 29.9%, p = 0.646) between the COVID-19 cohort and the control cohort. Overall, postoperative morbidity and mortality rates were comparable between both cohorts. History taking and reverse transcription polymerase chain reaction (RT-PCR) were used as preoperative screening methods to detect a possible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in all centers. No patients were diagnosed with COVID-19 pre- or postoperatively. CONCLUSION: Esophageal cancer surgery during the first wave of the COVID-19 pandemic was not associated with an increase in pulmonary complications as no patients were diagnosed with COVID-19. Esophageal cancer surgery can be performed safely with the use of adequate preoperative SARS-CoV-2 screening methods. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-021-09886-z. Springer International Publishing 2021-04-08 2021 /pmc/articles/PMC8028574/ /pubmed/33830357 http://dx.doi.org/10.1245/s10434-021-09886-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Gastrointestinal Oncology Borgstein, Alexander B. J. Brunner, Stefanie Hayami, Masaru Moons, Johnny Fuchs, Hans Eshuis, Wietse J. Gisbertz, Suzanne S. Bruns, Christiane J. Nafteux, Philippe Nilsson, Magnus Schröder, Wolfgang van Berge Henegouwen, Mark I. Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title | Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title_full | Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title_fullStr | Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title_full_unstemmed | Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title_short | Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study |
title_sort | safety of esophageal cancer surgery during the first wave of the covid-19 pandemic in europe: a multicenter study |
topic | Gastrointestinal Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028574/ https://www.ncbi.nlm.nih.gov/pubmed/33830357 http://dx.doi.org/10.1245/s10434-021-09886-z |
work_keys_str_mv | AT borgsteinalexanderbj safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT brunnerstefanie safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT hayamimasaru safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT moonsjohnny safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT fuchshans safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT eshuiswietsej safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT gisbertzsuzannes safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT brunschristianej safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT nafteuxphilippe safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT nilssonmagnus safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT schroderwolfgang safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy AT vanbergehenegouwenmarki safetyofesophagealcancersurgeryduringthefirstwaveofthecovid19pandemicineuropeamulticenterstudy |